My Financial News from Austria, Financial

from Bing and Google News
Austria , Thursday 16 April 2026

HOOKIPA Pharma Announces Third Quarter 2022 Financial Results and Provides a Business Update

Published on: Sunday 13 November 2022

HOOKIPA Pharma Announces Third Quarter 2022 Financial Results and Provides a Business Update Major oncology collaboration and license agreement secured with Roche to develop HB-700 for KRAS-mutated cancers and an additional undisclosed oncology candidateInvestigational New Drug Application for HB-300 for the treatment of metastatic castration-resistant prostate cancer accepted by the FDAEnrollment in the Phase 2 study of HB-200 in combination with pembrolizumab is ongoing; next data update expected in the first half of 2023 NEW YORK and VIENNA, Austria, Nov. 14, 2022 (GLOBE NEWSWIRE) --


News source: https://finance.yahoo.com/news/hookipa-pharma-announces-third-quarter-120000270.html

Share this news on:  

RELATED NEWS

» HOOKIPA Pharma Announces Third Quarter 2022 Financial Results and Provides a Business Update
» Austria prepares to pump billions into Vienna power firm hit by price jump
» Austria Pledges Billions to Utility Hit by Power-Price Jump
» Austria grants 2-billion loan to struggling energy supplier
» EQS-News: AT&S Austria Technologie & Systemtechnik AG: AT&S starts new financial year with record quarter

HEADLINE NEWS